LGND May 2024 70.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
| Previous close | 2.9500 |
| Open | 1.8500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 70.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.8000 - 2.9500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksDon't Overlook These Top Medical Stocks as Q1 Earnings Approach
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
Zacks5 Biotech Stocks Worth Adding to Your Portfolio in 2024
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
ZacksAgios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
© 2024 Yahoo. All rights reserved.